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THE anti-inflammatory effect of a small molecular weight
antagonist of P- and E-selectin-dependent cell adhesion
was examined. The glycolipid sulphatide was shown to
block the adherence ofthrombin-activated rat platelets to
HL-60 cells. This interaction is known to be dependent on
P-selectin. The rat dermal reverse passive Arthus reaction
was used to assess the effect ofsulphatide on a neutrophil
dependent inflammatory response. Sulphatide dose-
dependently blocked both the vascular permeability in-
crease and cell infiltration after intraperitoneal adminis-
tration. These results show that a small molecular weight
compound which blocks P- and E-selectin dependent ad-
hesion in vitro can effectively block the inflammation
due to immune complex deposition. A compound with
this type of profile may have therapeutic potential in the
treatment of immune complex mediated diseases.
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Introduction
During an inflammatory response leukocytes must
adhere to the vascular endothelium before migrating
into the extravascular space. P- and E-selectin are
cell surface receptors that are expressed on activated
endothelial cells. 1,2 P-selectin is also expressed on
activated platelets. The selectins mediate, in part, the
initial adhesion of leukocytes to the endothelial
wall. These receptors have a similar extracellular
domain structure including an N-terminal lectin-like
domain, an epidermal growth factor related domain
and several complement regulatory protein repeat
elements. 4,5 The lectin domain is analogous to other
C-type Cai+-dependent lectins, suggesting that
cell-cell adhesion mediated by selectins is likely to
involve carbohydrate:protein interactions. P- and E-
selectin are known to recognize sialylated,
fucosylated lactosaminoglycans such as sialyl Lewis
x (sLeX). Therefore, carbohydrate based ligands are
a reasonable starting point in efforts to identify
antagonists of selectin-mediated adhesion. Such
antagonists could be efficient inhibitors of leukocyte
extravasation at sites of inflammation.
A recombinant P-selectin IgG chimera has been
shown to bind to the glycolipid sulphatide. The
finding that sulphatide can block P-selectin depend-
ent adhesion of U937 cells and human PMNs, sug-
gested that this glycolipid could have anti-inflamma-
tory activity. We now report that sulphatide effect-
ively inhibits the increase in vascular.permeability
and cell infiltration in the dermal reverse passive
Arthus reaction in rats. Sulphatide exemplifies a
simple class of carbohydrate-containing compounds
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which appear to act via this new anti-inflammatory
strategy.
Materials and Methods
Test compounds: Sulphatide (Bovine Brain) was pur-
chased from Sigma Chemical and was supplied as a
mixture of 3-sulphated galactosylceramides. The N-
acyl fatty acid was primarily nervonic acid (70%) and
the minor component contained lignoceric acid
(30%). Sulphatide was tested for endotoxin contami-
nation using a Limulus amoebocyte lysate assay. The
endotoxin contamination was 19 EU/5 mg
sulphatide. Lipopolysaccharide from Escherichia coli
serotype 0127:B8 and galactosylceramide were
purchased from Sigma.
Animals: Male Sprague-Dawley specific pathogen
free rats (250-300 g) were obtained from Hill Top Lab
Animals (Scottdale, PA). The rats were housed indi-
vidually in stainless steel cages and in accordance
with NIH guidelines. The animals were given free
access to food and water.
The effect of sulphatide on HL-60 cell binding to
immobilized selectin-Ig: The construction of soluble
fusion proteins of the extracellular domain of P- and
E-selectins has been described.4,1 These proteins
were purified from the medium of transfected cos
cells. The proteins contain the human lectin domain,
the EGF domain, and two complement repeats of the
human selectinsfused to the hinge, CH1 and CH2
domains of human IgG1. The assay for cell binding
to immobilized selectin receptor globulin was per-
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formed as described. Briefly, the wells of a 96-well
dish (Corning) were coated overnight with anti-
human Fc antibody diluted into 50 mM Tris pH 9.1
buffer, blocked with 1% non-fat dry milk in
Dulbecco’s phosphate buffered saline (DPBS), and
allowed to bind selectin Rg. Cells were labelled with
10 l.tM calcein acetoxymethyl ester (Molecular
Probes) for 30 min at 3 x 107 cells per ml at room
temperature. The blocked Rg-bound wells were
rinsed twice, and labelled cells were added for 30
min at room temperature. Unbound cells were re-
moved by aspiration and three washes of the wells.
Fluorescence in each well was determined using a
Millipore Cytofluor fluorescent plate reader.
Sulphatide (Sigma) was prepared as a 20 mg/ml stock
solution in dimethyl sulphoxide (DMSO), diluted in
DPBS to 2 mg/ml working solution, and briefly
sonicated prior to use. When sulphatide or other
inhibitors were tested, the selectin-Ig coated wells
were preincubated at room temperature for 15 min
with the inhibitor, and 200000 cells were added, to
yield the final indicated inhibitor concentration
in 160 l.tl of DPBS. Sulphatide had no effect on
the amount of selectin-Ig bound to the plate
(G. Todderud, unpublished observation).
Effect of sulphatide on the binding of activated rat
platelets to HL-60 cells: Male Sprague-Dawley rats
(250-300 g) were anaesthetized with metofane
(Pitman-Moore). The animals were exsanguinated by
drawing blood from the aorta into EDTA-containing
vacutainer tubes. Platelet-rich plasma was prepared
by centrifugation at 120 xg for 20 min. The platelets
were isolated by centrifuging the plasma at
1 200xg for 20 min. The platelet pellet was
resuspended in THBE buffer (Tyrodes salts, 5 mM
HEPES, 10 mM EDTA, and 0.2% BSA). The isolated
platelets were fluorescently labelled by incubation
with 10 l.tM calcein acetoxymethyl ester (Molecular
Probes) at 37C for 15 min. The labelled platelets
were pelleted and resuspended in THB (same buffer
as THBE except without EDTA) and activated with
thrombin (2 units/ml, at 107 cells/ml) for 10 min at
37C. HL-60 cells and platelets were fixed in 1%
formalin for 30 min. The HL-60 cells were then added
to the platelets and incubated at a ratio of 5 platelets
per HL-60 in the presence or absence of the indicated
concentration of inhibitor for 30 min. The adhesion
was determined on a FACScan flow cytometer, by
analysing the forward scatter and fluorescent inten-
sity of the mixed population. The platelets, which
appear at lower forward scatter values, were ex-
cluded by gating only the higher forward scatter HL-
60 cell present. The HL-60 cells with high fluorescent
intensity contain bound platelets. The percentage of
HL-60 cells in fluorescent and non-fluorescent
populations was determined, and plotted as a func-
tion of inhibitor concentration.
460 Mediators of Inflammation Vol 3. 1994
The effect of sulphatide on the rat dermal reverse
passive Arthus reaction: Male Sprague-Dawley rats
with jugular vein cannulae (250-300 g) were anaes-
thetized with a mixture of 100 mg/kg Ketaset (Fort
Dodge Laboratories) and 4 mg/kg Rompun (Miles,
Inc.) given intraperitoneally. Closely clipped dorsal
skin was injected intradermally (i.d.) with 0.6 mg
Anti-BSA (Sigma). Negative control animals received
an intradermal injection of saline. The antigen,
BSA (10 mg) was then administered via the jugular
vein. The BSA contained 1 l.tCi of 125I-BSA (specific
activity 1-5 l.tCi/t-tg). Sulphatide, galacto-sylcer-
amide or vehicle (0.5% Tween 80 in normal saline)
was administered by intraperitoneal injection 2 h
prior to intravenous BSA administration. The rats
were killed at 4 h by COg inhalation and 15 mm
punch biopsies of the reaction sites were taken. To
assess changes in vascular permeability the 125I con-
tent of the biopsies was determined by gamma
scintillation spectroscopy. Permeability indices were
calculated by measuring the ratio of radioactivity in
full thickness skin biopsies compared with radio-
activity present in 1 btl of plasma. The skin accumu-
lation of neutrophils was determined from the tissue
myeloperoxidase (MPO) content. The biopsy MPO
content was determined using a modified version of
the method described by Bradley et a1.11 Each 15 mm
punch biopsy was homogenized with a Brinkman
Polytron homogenizer in 10 ml of 0.5%
hexadecyltrimethyl ammonium bromide (HTAB) in
0.05 M potassium phosphate buffer (pH 6.0). After a
single freeze/thaw step the homogenate was
sonicated for 20 s and centrifuged at 1 000g for 10
min. A 0.05 ml aliquot of the supernatant was as-
sayed by mixing with 0.15 ml O-dianisidine (0.334
mg/ml) and 0.0005% hydrogen peroxide in 0.05 M
potassium phosphate buffer. Change in absorbance
at 450 nm was measured at room temperature using
a Vmax kinetic plate reader (Molecular Devices, Palo
Alto, CA). The results are expressed as the mean
mOD/min/biopsy. Selected skin tissues were evalu-
ated histologically. Skin biopsies were fixed in 10%
neutral buffered formalin, processed in the usual
way, embedded in paraffin, cut into 4 l.tm thick
sections, then stained with haematoxylin and eosin.
Results and Discussion
Sulphatide is a mixture of 3-sulphated galactosyl
ceramides in which the N-acyl fatty acid is primarily
nervonic and lignoceric acid (Fig. 1). Previous stud-
ies have demonstrated the importance of the sul-
phate group in binding P-selectin and inhibiting P-
selectin dependent adhesion in vitro. We therefore
used galactosylceramide as a negative control in the
in vivo experiments. Figure 2 demonstrates that
sulphatide can block the binding of HL-60 cells to
plates coated with soluble P- or E-selectin Ig fusionSelectin antagonist
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FIG. 2. Inhibition of binding of HL-60 cells to immobilized P-selectin-lg (El)
or E-selectin-lg () by sulphatide compared with binding of P-selectin-lg
in the presence of galactosylceramide (&). The number of fluorescent
labelled HL-60 cells bound to the plate coated with selecting-lg was deter-
mined in triplicate at each concentration tested. The standard deviations
are within the symbols, and this is representative of four separate
determinations.
proteins. Galactosylceramide had no effect. The
demonstration that sulphatide can block E-selectin-
dependent adhesion is interesting in view of the
reported finding that E-selectin does not bind to
immobilized sulphatide.4,6 However, it is known that
sulphated analogues of sLex can bind to E-selectin
with a greater affinity than sLex. 12 Platelets are known
to bind to HL-60 cells in a P-selectin dependent
manner. ’3 To show that sulphatide can block a cell-
cell interaction, we evaluated the effect on the adhe-
sion of activated rat platelets to HL-60 cells by flow
cytometry. Figure 3 shows that sulphatide dose-
dependently blocks this cell-cell adhesion. Taken
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FIG. 3. Inhibition of binding of activated rat platelets to HL-60 cells. The
percentage of HL-60 cells which contain bound activated platelets (apl) was
determined by flow cytometry. The closed bars show the result of treatment
with the DMSO vehicle (veh) or 10 mM EDTA (edta), and binding in the
presence of the indicated concentrations of sulphatide is shown by the
open bars.
together, these data show that sulphatide inhibits
both human P- and E-selectin and that the effect can
be extended across species to rat P-selectin.
The reverse passive Arthus reaction is an immedi-
ate hypersensitivity reaction initiated by immune
complex depositions in the vascular wall followed by
complement fixation resulting in increased vascular
permeability and polymorphonuclear leukocyte
(PMN) infiltration. TM This acute reaction may be in-
volved in autoimmune diseases characterized by
immune complex deposition. For example, in
rheumatoid arthritis circulating and intraarticular
immune complexes appear to play a role in the
pathogenesis of the disease. ’5 E-selectin has been
shown to be involved in the inflammation resulting
from an Arthus reaction in both rat skin and lungs.6
The role of P-selectin in the Arthus reaction has not
been determined. However, P-selectin does play a
role in neutrophil dependent lung injury,
7 and P-
selectin deficient mice exhibit delayed inflammatory
reactions18 suggesting a role for this adhesion mol-
ecule in inflammation. Table 1 shows the dose-
related inhibitory effect of sulphatide on vascular
permeability and PMN infiltration. By contrast, the
nonsulphated galactosylceramide at 100 mg/kg had
no effect on vascular permeability or PMN infiltra-
tion. In data not shown, sulphatide had no effect on
circulating PMN numbers. In addition, the anti-
inflanmtory effect was not due to endotoxin contami-
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FIG. 4. Light micrographs of H&E stained rat skin following Arthus reaction (magnification x 90). Compared with the negative control (A) the intradermal sites
in animals treated with the vehicle (B) and galactosylceramide (C) showed cell infiltration as indicated by the arrows. Compared with the vehicle treated group,
animals treated with sulphatide (D) showed a reduction in infiltrating cells. Rats were administered sulphatide (100 mg/kg), galactosylceramide (100 mg/
kg) or vehicle as described in the legend to Table 1. Full thickness skin biopsies fixed in 10% buffered formalin were prepared as vertical sections and stained
with H&E.
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Table 1. The effect of sulphatide and galactosylceramide on the rat
dermal reverse passive Arthus reaction
Dose Vascular PMC
(mg/kg) permeability infiltration
Vehicle control 287 _+ 8 363 + 46
Sulphatide 5 278 + 26 330 + 48
20 294 + 16 194 + 36*
50 266 + 13 179 + 36*
100 231 + 19 145 + 25*
Galactosylceramide 100 286 + 8 404 _+ 50
aTest materials were administered by intraperitoneal injection 2 h
prior to anti-BSA injection. The vehicle was composed of 0.5%
Tween 80 in normal saline.
bVascular permeability increases were measured as the accumu-
lation of tissue 12SI-BSA. The values represent mean #1 of plasma
+ SEM (n 8).
CRelative PMN infiltration was quantitated from the tissue
myeloperoxidase (MPO) level. The values represent mean MPO
activity (mOD/min/biopsy) + SEM (n 8).
*p > 0.05 compared with vehicle control. Statistical differences
were analysed by paired Student’s t-test.
nation since administration of LPS in doses of at least
96 EU/kg had no effect on the vascular permeability
or cell infiltration parameters (X. Nair, personal ob-
servation). Figure 4 shows the microscopic changes
induced by the RPA reaction in rat skin. Extensive
extravascular cell infiltration and dermal oedema are
apparent in the reaction sites following vehicle or
galactosylceramide administration. In contrast,
sulphatide caused a marked reduction in cell infiltra-
tion compared with vehicle and galactosylceramide.
These results show that a small molecular weight
compound which blocks P- and E-selectin depend-
ent cell adhesion in vitro can effectively block the
inflammation due to immune complex deposition. L-
selectin has also been shown to bind sulphatide.6,1
Inhibition of L-selectin-dependent adhesion by
sulphatide could contribute to the anti-inflammatory
effect since soluble L-selectin chimeras and anti-L-
selectin F(ab’)2 antibody fragments have been shown
to block PMN infiltration in several animal mod-
els. 19’2 Therefore, the results we report here do not
shed additional light on the relative roles of P-, E-
and L-selectin in PMN recruitment. However, these
observations support the concept that compounds
which block selectin dependent adhesion may
have therapeutic potential in the treatment of acute
inflammatory reactions where PMN infiltration is
predominant.
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